Egor N. Grebenkin

Egor N. Grebenkin

Auto-generated profile, based on publicly available information

Egor N. Grebenkin

Kursk Oncology Research and Clinical Center named after. G.E. Ostroverkhov

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Pirogov Russian Journal of Surgery
Verified
Journal Article
Closed access
PDF file
GAG. G. Akhaladze
G. G. Akhaladze
EGE. N. Grebenkin
E. N. Grebenkin
SGS. V. Goncharov
S. V. Goncharov
USU. S. Stanoevich
U. S. Stanoevich
AAA. A. Abramov
A. A. Abramov
AMA. Zh. Makhambetov
A. Zh. Makhambetov
Vascular leiomyosarcoma (LMS) is an extremely rare disease. Venous lesion is approximately 5 times more common than arterial. LMS is usually found in retroperitoneal veins and in inferior vena cava. Lesion of the splenic vein is extremely rare. A 52-year-old woman with recurrent abdominal pain is reported in the article. Abdominal contrast-enhanced CT revealed a 6 cm tumor of the pancreatic tail. The patient underwent laparoscopic distal pancreatectomy with splenectomy en bloc. Histological and immunohistochemical studies revealed LMS originating from the smooth muscles of the splenic vein. Surgery was followed by adjuvant chemotherapy. There was no local recurrence in 1 year after surgery. In this article, we analyze the available information on leiomyosarcoma of the splenic vein.

21 March 2021 in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
Verified
Journal Article
Open access
PDF file
VSV. A. Solodkiy
V. A. Solodkiy
GAG. G. Akhaladze
G. G. Akhaladze
EGE. N. Grebenkin
E. N. Grebenkin
SGS. V. Goncharov
S. V. Goncharov
ISIrina Vasil’evna Stanoevich
Irina Vasil’evna Stanoevich
OIO. A. Ivanova
O. A. Ivanova
Aim. To improve the surgical treatment results among patients with synchronous liver metastasis of colorectal cancer. Materials and methods. From 2012 to 2019, the analysis of the results of treatment of 60 patients with colorectal cancer and synchronous metastatic liver disease was carried out. The study sample was divided into 2 groups of patients. The group 1 consisted of 30 patients who got simultaneous resection of liver metastases and primary colorectal cancer. The group 2 consisted of other 30 patients who got stage resections: surgery for the primary tumor at the first stage, and liver surgery for metastases at the second.Results. The median operative time was 340 ± 21.1 minutes in the group 1. In the group 2 it was 255 ± 21.1 minutes and only the liver resection stage was assessed. The median blood loss in patients of the group 1 was 520,0 [200,0;800,1] ml, in the group 2 it was 500,0 [175,0;1300,0] ml. In general, we identified 5 cases of complications. In the postoperative period, 4 patients died. The average follow-up period is 23 months. One-year survival in group 1 was 92.6%, in group 2 – 100%, three-year – 85.2% and 89.6%. One-year disease-free survival in group 1 is 70%, in group 2 – 83.3%, three-year disease-free survival – 43.3% and 36.7%.Overall and disease-free survival rates didn’t differ significantly between the two treatment strategies. We detected significant effect on the disease-free and overall survival of regional lymph nodes metastasis (both p < 0.05).Conclusion. The long-term and immediate results of simultaneous surgery of synchronous liver metastasis of colorectal cancer are comparable to the results of the staged method of treatment. It indicates the safety and effectiveness of simultaneous procedure.

15 July 2022 in Journal of Modern Oncology
Verified
Journal Article
Open access
PDF file
APAlexandr N. Perepelevskiy
Alexandr N. Perepelevskiy
USUgljesa S. Stanojevic
Ugljesa S. Stanojevic
VLViktor A. Lazarenko
Viktor A. Lazarenko
EGEgor N. Grebenkin
Egor N. Grebenkin
OSOlga E. Sumina
Olga E. Sumina
ISIrina Vasil’evna Stanoevich
Irina Vasil’evna Stanoevich
Background. Morphological verification of central and peripheral focal lung neoplasms is a difficult task for modern minimally invasive methods of differential diagnosis. The use of transthoracic trepanobiopsy of lung neoplasms under the control of computed tomography (CT) allows you to obtain informative, histological material and make a correct diagnosis. Aim. The aim of the study was to determine the possibility and safety of performing transthoracic trepanobiopsy of lung tumors under the control of CT in patients who are on an outpatient appointment in a third-level institution in order to obtain informative histological material. Materials and methods. From January 2020 to April 2021, 65 patients underwent transthoracic trepanobiopsy of focal lung neoplasms under the control of CT on an outpatient basis in the polyclinic department of the Ostroverkhov Kursk Cancer Research and Clinical Center. Results. The average time spent on performing a biopsy, with preliminary marking under CT control, was 15.14.5 minutes. In 2 (3.1%) cases, the morphological material was uninformative. The informativeness of the performed trepanobiopsies for the verification of the lung tumor process was 96.9%. Complications were observed in 5 (7.6%) patients: pneumothorax in 4 (6.1%), hemoptysis in 1 (1.5%). Pneumothorax occurred mainly in patients aged 5567 years. Conclusion. The used method of transthoracic lung trepanobiopsy under CT control should be used in outpatient settings of third-level institutions for morphological confirmation of the diagnosis, since it is safe and highly informative for patients, which is confirmed by a low percentage of complications (7.6%) and allows for differential diagnosis of focal lung neoplasms at the pre-hospital stage.

15 December 2022 in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
Verified
Journal Article
Open access
PDF file
OIO. A. Ivanova
O. A. Ivanova
GAG. G. Akhaladze
G. G. Akhaladze
SGS. V. Goncharov
S. V. Goncharov
EGE. N. Grebenkin
E. N. Grebenkin
ISIrina Vasil’evna Stanoevich
Irina Vasil’evna Stanoevich
VSV. A. Solodkiy
V. A. Solodkiy
Aim. To analyze studies focused on comparing laparoscopic and open simultaneous surgeries for synchronous metastases of colorectal cancer in the liver.Materials and methods. The electronic databases PubMed, Web of Science, Scopus, Embase, Cochrane Library were searched for the studies focused on the comparison of open and laparoscopic simultaneous surgeries for synchronous metastatic liver lesions, dated till October 20, 2020. Keywords: simultaneous resections, colorectal cancer, liver metastases, simultaneous laparoscopic.Results. Meta-analysis contains the results of 1211 simultaneous surgeries for simultaneous metastases of colorectal cancer in the liver: 450 laparoscopic and 761 open surgeries. Laparoscopic surgery was characterized with lower blood loss [weighted mean difference (WMD) = -131.77, 95% CI: -232.54 to -31.00, p = 0.01], a shorter postoperative hospitalization [WMD = -2.87, 95% CI: -3.41 to -2. 33, p < 0.00001], early first bowel movement [WMD = -0.99, 95% CI: -1.40 to -0.58, p < 0.0001], early initiation of enteral feeding [WMD = -1.20, 95% CI: -2.06 to -0.33, p = 0.007]), lower incidence of postoperative complications [OR = 0.60, 95% CI: 0.46–0.80, p = 0.0004]. A statistically significant advantage of laparoscopic access was established in overall [OR = 0.80, 95% CI: 0.64–0.99, p = 0.04] and recurrence-free survival [OR = 0.73, 95% CI: 0.60–0.89, p = 0.002].Conclusion. Perioperative and distant oncologic outcomes demonstrate safety and efficacy of laparoscopic simultaneous interventions for synchronous metastases of colorectal cancer in comparison with open interventions.

1 January 2013
Verified
Journal Article
Closed access
VCV D Chkhikvadze
V D Chkhikvadze
USU S Stanoevich
U S Stanoevich
PKP G Kolesnikov
P G Kolesnikov
EGE N Grebenkin
E N Grebenkin

23 April 2024 in P.A. Herzen Journal of Oncology
Verified
Journal Article
Closed access
EGE.N. Grebenkin
E.N. Grebenkin
MPM.B. Polyanskii
M.B. Polyanskii
APA.N. Perepelevskii
A.N. Perepelevskii
AMA.S. Mazalova
A.S. Mazalova
MTM.V. Temirbulatov
M.V. Temirbulatov
High incidence, poor prognosis, risk of progression after radical surgical treatment, cellular and molecular genetic heterogeneity of gastric cancer represent a serious health problem worldwide; the annual death rate is more than 700.000 cases. Understanding oncogenesis, risk factors, and the use of new approaches to treating this pathology are priority tasks of modern oncology. This review is devoted to modern ideas about carcinogenesis, assessment of the morphologically unchanged gastric mucosa through the prism of the precancerous Correa cascade. The basic molecular mechanisms and signaling pathways of carcinogenesis are described, and the tumor microenvironment is characterized.